Skip to main content

Animations

MJFF Publications

3841 - 3850 of 6082 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's disease
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cortex.2019.09.015
    Citation Count: 16
  • Summary Details
    OPEN
    Title: New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.06.4956
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain
    DOI - Digital Object Identifier: 10.1093/brain/awz350
    Citation Count: 199
  • Summary Details
    OPEN
    Title: [18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-019-04533-y
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Genetic architecture of subcortical brain structures in 38,851 individuals
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-019-0511-y
    Citation Count: 253
  • Summary Details
    OPEN
    Title: A novel approach to study markers of dopamine signaling in peripheral immune cells
    Journal Name: Journal of Immunological Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jim.2019.112686
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPases
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.201902184
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Neuropsychological Test Performances and Depression in Early-Stage De Novo Parkinson’s Disease
    Journal Name: Archives of Clinical Neuropsychology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/arclin/acz067
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aau6870
    Citation Count: 94
  • Summary Details
    OPEN
    Title: Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104623
    Citation Count: 74
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.